Ending Eclampsia, 2019 This gap analysis not only provides insights into the quality of care women with HDP received postnatally, as well as the outcomes for them and their infants, health statuses, and morbidity patterns, but will improve policy-makers’ and…
Tag Archive for hypertension
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
The Lancet, August 2019 Results showed that alll oral antihypertensives reduced blood pressure to the reference range in most women. As single drugs, nifedipine retard use resulted in a greater frequency of primary outcome attainment than labetalol or methyldopa use.…
Midwives Can Reduce the Number of Preventable Deaths From Pre-Eclampsia: Research from Kenya and Nigeria
By Amy Dempsey Sunday, May 5 is International Day of the Midwife, a global advocacy day dedicated to raising awareness of the importance of these defenders of women’s rights. To raise awareness, please read and share the International Confederation of Midwives’ social media…
Antihypertensive drugs for high blood pressure in pregnancy
Ending Eclampsia, 2019 This brief describes the challenges to ensuring women have access to antihypertensive drugs to control their BP during pregnancy, challenges that include national task shifting policies, frequent stock outs, health worker trainings, and inadequate support for task shifting…
Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials
British Journal of Clinical Pharmacology, 2018 This network meta-analysis suggests similar efficacy nifedipine, hydralazine, and labetalol in the treatment of severe hypertension in pregnancy. The above drugs may also be useful in treating hypertension in severe pre-eclampsia. Moderate quality of evidence was observed for direct comparison…
Nutrition and pre-eclampsia risk factors in Ethiopia
By Khadijah Alibhai In Ethiopia, 412 women die per 100,000 live births. Most of these deaths are preventable, and 19 percent of them are from hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia (PE/E). Typically, pre-eclampsia is detectable during early…
The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: A case control study
Hypertension in Pregnancy, 2016 Intravenous administration of magnesium sulfate in pregnant women with severe pre-eclampsia resulted in a decrease in umbilical artery, uterine artery, and fetal middle cerebral artery Doppler indices and reduced resistance to blood flow.
Effects of Lactation on Postpartum Blood Pressure Among Women with Gestational Hypertension and Pre-eclampsia
American Journal of Obstetrics & Gynecology, 2016 This study found that lactation is associated with lower postpartum blood pressure among overweight women who develop gestational hypertension, but not among women who develop pre-eclampsia. Future studies are needed to explore association…
Risk factors for pre-eclampsia and eclampsia in Mexico
Ending Eclampsia, 2018 This infographic provides data on risk factors, policies, health system capacity and community perceptions in Mexico-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery…
Assessing feasibility and acceptability of CHEWs treating hypertension in pregnancy
Ending Eclampsia, 2018 The research team is measuring outcomes such as proper diagnosis and classification of hypertensive disorders, appropriate use of antihypertensive drugs, effective control of hypertension, use of MgSO4 when necessary, and maternal and fetal outcomes.
